According to key opinion leaders, positive SURMOUNT-5 results, alongside Lilly’s business strategy, means Zepbound is set to ...

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Eli Lilly's Zepbound is challenging Wegovy in the obesity market, while U.S. health care costs are set to rise 9% in 2025, driven by specialty drugs and inflation.

Kennedy Jr., President-elect Donald Trump’s nominee to head the US Department of Health and Human Services, who has expressed reservations about the pharma industry — and its new wonder drug category.

Encouraging primary care physicians to screen patients for physical inactivity with a simple questionnaire can help identify ...

The drug and biotech industry had a tough time in the past couple of months after Trump announced the appointment of Robert F ...

Driver Rams Pickup Into Crowd in New Orleans, Killing 10 LIVE Suspect Is Dead; F.B.I. Is Investigating as Terror Attack The suspect, who is dead after a shootout with ...

Driver Rams Pickup Into Crowd in New Orleans, Killing 10 LIVE Attacker’s Truck Had Islamic State Flag, F.B.I. Says Officials said they did not believe the suspect, who died after a shootout with ...

Healthline News reports on emerging research, new treatments, diet, exercise, and trending topics in health and wellness. All articles are written by our network of editors and contributors ...